Highly expressed KYNU alters the metabolic microenvironment of tumor cells, promoting the induction and infiltration of regulatory T cells (Tregs) and increasing the expression of immune checkpoint molecules PD1 and PD-L1 [36]. This evidence concerns the gene CD274 and neoplasm.